Table 1.
Antimicrobial exposure among residents colonized and not colonized with Clostridium difficile
Antimicrobial group N (%) | Controls (C. difficile−) N = 21 |
Cases (C. difficile +) N = 7 |
P value |
---|---|---|---|
Penicillins | 1 (5) | 0 | 1.00 |
Extended spectrum penicillins | 3 (14) | 0 | 0.55 |
First-generation cephalosporins | 3 (14) | 1 (14) | 1.00 |
Other cephalosporins | 4 (19) | 3 (43) | 0.32 |
Carbapenems | 1 (5) | 1 (14) | 0.44 |
Quinolones | 7 (33) | 0 | 0.14 |
Azithromycin | 1 (5) | 0 | 1.00 |
Doxycycline | 0 | 0 | – |
Trimethoprim-sulfameth-oxazole | 2 (10) | 3 (43) | 0.08 |
Nitrofurantoin | 4 (19) | 1 (14) | 1.00 |
Gentamicin | 0 | 0 | – |
Vancomycin | 2 (10) | 0 | 1.00 |
Linezolid | 0 | 0 | – |